Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers

2 Dec 2021

Abstract excerpt

Blood disorders include a wide spectrum of blood-associated malignancies resulting from inherited or acquired defects. The ineffectiveness of existing therapies against blood disorders arises from different reasons, one of which is drug resistance, so different types of leukemia may show different responses to treatment. Leukemia occurs for a variety of genetic and acquired reasons, leading to uncontrolled...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kruppel-like factors research
Share to MicroRNA in disease regulation
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35685482
DOI: 10.1016/j.gendis.2021.10.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancersPMID 35685482Read ↗

New therapeutic axis in blood malignancies involving microRNAs and JAK/STAT3 signalingSemantic proximity Read ↗

Roles of STAT3 in leukemia (Review)Semantic proximity Read ↗

microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemiaSemantic proximity Read ↗

Interplay between microRNAs and the STAT3 signaling pathway in human cancersSemantic proximity Read ↗

JAK-STAT pathway in hematological malignancies: achievements, challenges and future perspectivesSemantic proximity Read ↗

STAT3 Inhibitors: Finding a Home in Lymphoma and LeukemiaSemantic proximity Read ↗

STATs: An Old Story, Yet Mesmerizing.Semantic proximity Read ↗

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discoverySemantic proximity Read ↗

The relationship between microRNAs and the STAT3-related signaling pathway in cancerSemantic proximity Read ↗

STAT3 Signaling in CancerSemantic proximity Read ↗

The potential and controversy of targeting STAT family members in cancerSemantic proximity Read ↗

JAK/STAT in leukemia: a clinical updateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.